Infographic: Cardiac Safety in Phase 1 Clinical Trials

Cardiac safety is a critical milestone in every early-phase study.
So why are so many potentially safe and effective drugs dropped early in development?

The answer is simple. Poor data quality, inaccurate recognition of long QT, and inconsistent measurements are undermining your success — and costing you money. Luckily, there’s a solution. Simplified QT readings can transmit ECGs from any site in the world to a single database, centralizing your cardiac data and storing it for accurate, reliable analyses when the time comes.

See how it works in this infographic. You can view it below, or download it here.

Cardiac Safety in Phase 1 Clinical Trials - Are You Over-Investing?
Rethink Paper ECGs for Cardiac Safety in Phase 1 Clinical Trials
Share